Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Balyasny Asset Management L.P. WW Ww International, Inc. 13G 8.26% 2y
AQR CAPITAL MANAGEMENT LLC AFAR Aura FAT Projects Acquisition Corp Class A Ordinary Shares 13G/A 3.44% 2y
RTW INVESTMENTS, LP RARE Ultragenyx Pharmaceutical Inc. 13G/A 8.4% 2y
ORBIMED ADVISORS LLC APLT Applied Therapeutics, Inc. Common Stock 13G/A 0% 2y
RA CAPITAL MANAGEMENT, L.P. CELC Celcuity Inc. 13G/A 5% 2y
BAKER BROS. ADVISORS LP CYT Cyteir Therapeutics, Inc. Common Stock 13G/A 0% 2y
AWM Investment Company, Inc. ECOR electroCore, Inc. 13G/A 9.99% 2y
EcoR1 Capital, LLC ARVN Arvinas, Inc. 13G/A 9.99% 2y
Vellar Opportunities Fund Master, Ltd. ICU SeaStar Medical Holding Corp 13G/A 0% 2y
AQR CAPITAL MANAGEMENT LLC SBXC SilverBox Corp III 13G 5.21% 2y
PRICE T ROWE ASSOCIATES INC /MD/ XPRO Expro Ltd 13G/A 8.5% 2y
Teachers Advisors, LLC ALT Altimmune, Inc. 13G/A 2.88% 2y
Richard K. Crumly XPEL XPEL, Inc. 13G/A 5.1% 2y
Fund 1 Investments, LLC TTSH Tile Shop Holdings, Inc. 13G/A 11.45% 2y
CVI Investments, Inc. EBON Ebang International Holdings Inc. 13G 6.8% 2y
M3 Funds, LLC BFIN BankFinancial Corporation 13G/A 9.21% 2y
Third Rock Ventures IV, L.P. VYGR Voyager Therapeutics, Inc. 13G/A 0.4% 2y
TANG CAPITAL MANAGEMENT, LLC KNTE Kinnate Biopharma Inc. Common Stock 13G/A 5.5% 2y
Whitefort Capital Management, LP ABUS Arbutus Biopharma Corp 13G/A 7.9% 2y
Wynnefield Partners Small Cap Value, L.P. QRHC Quest Resource Holding Corp 13G/A 13.7% 2y
Avoro Capital Advisors LLC XENE Xenon Pharmaceuticals Inc. 13G/A 7.7% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC KCGI Kensington Capital Acquisition Corp. V 13G 8.81% 2y
Aristotle Capital Management, LLC CBSH Commerce Bancshares Inc 13G/A 6.78% 2y
BIOTECHNOLOGY VALUE FUND L P IMA ImageneBio, Inc. 13G/A 9.9% 2y
Gates Capital Management, Inc. VSTO Vista Outdoor Inc. 13G/A 9.1% 2y
Sandia Investment Management LP PEPL PepperLime Health Acquisition Corporation Class A Ordinary Share 13G/A 0% 2y
ALLIANCEBERNSTEIN L.P. HLI Houlihan Lokey, Inc. 13G/A 1.6% 2y
EdgePoint Investment Group Inc. MAT Mattel Inc 13G/A 13% 2y
Omega Fund VI, L.P. ALPN Alpine Immune Sciences, Inc. Common Stock 13G/A 0% 2y
SAMLYN CAPITAL, LLC INZY Inozyme Pharma, Inc. Common Stock 13G 5.5% 2y
Dragoneer Investment Group, LLC JAMF Jamf Holding Corp. Common Stock 13G/A 13.1% 2y
FIR TREE CAPITAL MANAGEMENT LP TGVC TG Venture Acquisition Corp. Class A Common Stock 13G/A 0% 2y
Par Sanda BHM Bluerock Homes Trust, Inc. 13G/A 13.04% 2y
Chi Fung Cheng CRDO Credo Technology Group Holding Ltd 13G/A 6.5% 2y
AMERIPRISE FINANCIAL INC AIRG Airgain Inc 13G/A 5.92% 2y
William R. Kruse REI Ring Energy, Inc. 13G/A 7% 2y
BIOTECHNOLOGY VALUE FUND L P ETNB 89bio, Inc. Common Stock 13G/A 7.8% 2y
PRICE T ROWE ASSOCIATES INC /MD/ RLAY Relay Therapeutics, Inc. 13G 7% 2y
Granahan Investment Management, LLC GENI Genius Sports Ltd 13G 6.27% 2y
GLAZER CAPITAL, LLC IVCB Investcorp Europe Acquisition Corp I Class A Ordinary Shares 13G/A 9.93% 2y
Deep Track Capital, LP ISEE IVERIC bio, Inc. Common Stock 13G/A 0% 2y
D. E. Shaw & Co., L.P. PEGR Project Energy Reimagined Acquisition Corp. Class A Ordinary Share 13G/A 1.1% 2y
Paradigm Biocapital Advisors LP NUVL Nuvalent, Inc. 13G/A 6.7% 2y
CADIAN CAPITAL MANAGEMENT, LP BRZE Braze, Inc. 13G/A 2.3% 2y
OLP CAPITAL MANAGEMENT Ltd QFIN Qfin Holdings, Inc. 13G 8% 2y
FIR TREE CAPITAL MANAGEMENT LP DPCS DP Cap Acquisition Corp I Class A Ordinary Shares 13G 9.06% 2y
BIOTECHNOLOGY VALUE FUND L P JSPR Jasper Therapeutics, Inc. 13G/A 0% 2y
Oaktree Opps Xb Holdco Ltd. EXE EXPAND ENERGY Corp 13G/A 5.34% 2y
MOORE CAPITAL MANAGEMENT, LP SUAC ShoulderUp Technology Acquisition Corp. 13G 6% 2y
PERCEPTIVE ADVISORS LLC FOLD AMICUS THERAPEUTICS, INC. 13G/A 9.6% 2y